Stevens L M, Hughes D C, Anderson J P. "一种的合成方法" [P]. US Patent, US 10269186 B2, 2022-05-11.
发明人赵玉洁,胡光,罗永刚. "Method for the Synthesis of 2-[1-(Chloroacetyl)-3-oxopiperazin-2-yl]-N-(3-chlorophenyl)acetamide" [P]. 中国发明专利, 专利号 CN 114526643 A, 授权公告日 2021-12-23.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2016, 430, (5), 7742-7760.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2020, 917, 9356-9374.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 2-[1-(Chloroacetyl)-3-oxopiperazin-2-yl]-N-(3-chlorophenyl)acetamide Using HRMS and NMR". Sci. Total Environ., 2018, 1804, (1), 5030-5054.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2023, 1007, 736-763.